Investigational Clinical Trials for Hematologic (Blood) Cancers

Hematologic cancers begin in blood-forming tissues such as the bone marrow or in the cells of the immune system. Another name for hematologic cancer is blood cancer. Types of blood cancer include:

Acute Myeloid Leukemia (AML)
Burkitt Lymphoma
Chronic Lymphocytic Leukemia (CLL)
Diffuse Large B-Cell Lymphoma (DLBCL)
Follicular Lymphoma (FL)
Hodgkin Lymphoma

Mantle Cell Lymphoma (MCL)
Marginal Zone Lymphoma (MZL)
Multiple Myeloma
Richter’s Transformation (RT)
Small Lymphocytic Lymphoma (SLL)
Waldenstrom’s Macroglobulinemia (WM)

Blood cancer clinical trials study investigational medications either alone, or in combination with other study medications, or standard of care therapy.

Current clinical trials for blood cancers explore investigational medications including: pembrolizumab, vibostolimab, nemtabrutinib, zilovertamab vedotin, or favezelimab.

There is a lot to consider when deciding whether to participate in a clinical trial. Any clinical trial includes risks, which the study doctor will review with you. Make sure you understand the risks before participating.

Explore hematologic cancer clinical trials that are enrolling volunteers

Below is a list of all available hematologic cancer clinical trials. You can narrow the results by choosing options in the dropdown menus below. You can also sort results to show trials nearest to you by entering your city or postal code in the search field.

Resources for patients

For help understanding clinical trial listings and for other resources, visit the Patient Resources section.

Browse resources

About clinical trials

Learn what clinical trials are, how they work, and if you may be eligible to participate.

Learn more